Vanda Pharmaceuticals Inc., Washington, DC, USA.
Sci Rep. 2020 Feb 17;10(1):2721. doi: 10.1038/s41598-020-59627-7.
The genetic background of Atopic Dermatitis (AD) with chronic pruritus is complex. Filaggrin (FLG) is an essential gene in the epidermal barrier formation s. Loss-of-function (LOF) variants in FLG associated with skin barrier dysfunction constitute the most well-known genetic risk factor for AD. In this study, we focused on the frequency and effect of FLG loss-of-function variants in association with self-reported age-of-onset of AD. The dataset consisted of 386 whole-genome sequencing (WGS) samples. We observe a significant association between FLG LOF status and age-of-onset, with earlier age of onset of AD observed in the FLG LOF carrier group (p-value 0.0003, Wilcoxon two-sample test). We first tested this on the two most prevalent FLG variants. Interestingly, the effect is even stronger when considering all detected FLG LOF variants. Having two or more FLG LOF variants associates with the onset of AD at 2 years of age. In this study, we have shown enrichment of rare variants in the EDC region in cases compared with controls. Age-of-onset analysis shows not only the effect of the FLG and likely EDC variants in terms of the heightened risk of AD, but foremost enables to predict early-onset, lending further credence to the penetrance and causative effect of the identified variants. Understanding the genetic background and risk of early-onset is suggestive of skin barrier dysfunction etiology of AD with chronic pruritus.
特应性皮炎(AD)伴慢性瘙痒的遗传背景复杂。丝聚合蛋白(FLG)是表皮屏障形成的必需基因。FLG 中的功能丧失(LOF)变体与皮肤屏障功能障碍相关,是 AD 最著名的遗传风险因素。在这项研究中,我们专注于与 AD 发病年龄相关的 FLG 功能丧失变异的频率和效应。该数据集由 386 个全基因组测序(WGS)样本组成。我们观察到 FLG LOF 状态与发病年龄之间存在显著关联,FLG LOF 携带者组的 AD 发病年龄更早(p 值 0.0003,Wilcoxon 两样本检验)。我们首先在两种最常见的 FLG 变异体上进行了测试。有趣的是,当考虑所有检测到的 FLG LOF 变异体时,效果甚至更强。携带两个或更多 FLG LOF 变异体与 AD 在 2 岁时发病相关。在这项研究中,我们已经表明,与对照组相比,病例中 EDC 区域的稀有变异体富集。发病年龄分析不仅显示了 FLG 和可能的 EDC 变异体在 AD 风险增加方面的效应,而且主要能够预测早发性,进一步证明了所鉴定变异体的外显率和因果效应。了解早发性的遗传背景和风险提示了慢性瘙痒性 AD 的皮肤屏障功能障碍病因。